InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Bashan Dror, 首席执行官. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Cumulatively, 7 reports have been logged. Split: 3 buys · 0 sell. Total volume traded: €244k. Activity tracked since 11 April 2022. The latest transaction was disclosed on 19 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Bashan Dror is President and CEO at Protalix BioTherapeutics, Inc. (XNAS). He has 7 filings in total, and across the recent filings reviewed, buys amount to EUR 244199 and sells to EUR 0, between 2022-02-28 and 2025-12-23, with the transaction nature mainly indicated as Attribution.